Abstract:Investigations on the disposition of the highly effective aldose reductase inhibitor ALO 1576 were carried out in pigmented rats after oral dosing and topical administration of a 0.1 % ophthalmic suspension by means of an assay modified from a previously described method measuring aldose reductase activity. The crude enzyme extract of pig lenses was used as a test system. From the activity remaining after addition of the plasma or lens extracts, the concentration could be determined since the inhibition consta… Show more
“…Primary in vitro screening was conducted on a water-soluble enzymatic extract purified from rat lenses [21][22][23][24]. IC 50 values were determined by linear regression analysis of the log of the concentration-response curve.…”
“…Primary in vitro screening was conducted on a water-soluble enzymatic extract purified from rat lenses [21][22][23][24]. IC 50 values were determined by linear regression analysis of the log of the concentration-response curve.…”
“…Primary in vitro screening was performed on a water-soluble crude enzymatic extract of rat lenses. [22][23][24][25] IC 50 values were determined by using linear regression analysis of the log concentration-response curve. Sorbinil, 26 tolrestat, 27,28 and quercetin 29 were used as the reference standards.…”
Section: Biology and Pharmacologymentioning
confidence: 99%
“…The diastereomeric mixtures of the target compounds 39 − 57 were used as such to evaluate their in vitro inhibitory activity against ALR2. Primary in vitro screening was performed on a water-soluble crude enzymatic extract of rat lenses. − IC 50 values were determined by using linear regression analysis of the log concentration−response curve. Sorbinil, tolrestat, , and quercetin were used as the reference standards.…”
Cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives were synthesized and tested as a novel class of aldose reductase (ALR2) inhibitors. Each compound was evaluated as a diastereomeric mixture, due to tautomeric equilibria in solution. The parent compound 39 exhibited a good inhibitory activity with an IC(50) value of 0.85 microM, similar to that of the well-known ARI sorbinil (IC(50) 0.50 microM). The concurrent introduction of a halogen and a lipophilic group in the 5- and in the 1-positions, respectively, of the indole nucleus of 39, gave compound 55, cyano[5-fluoro-1-(4-methylbenzyl)-2-oxo-2,3-dihydroindol-3-yl]acetic acid, which displayed the highest activity (IC(50) 0.075 microM, very close to that of tolrestat IC(50) 0.046 microM), with a good selectivity toward ALR2 compared with aldehyde reductase (ALR1) (16.4-fold), and no appreciable inhibitory properties against sorbitol dehydrogenase (SD), or glutathione reductase (GR). The isopropyl ester 59, a prodrug of 55, was found to be almost as effective as tolrestat in preventing cataract development in severely galactosemic rats when administered as an eye drop solution. Docking simulation of 55 into a three-dimensional model of human ALR2 made it possible to formulate the hypothesis that the 2-hydroxy tautomer was the active species binding into the catalytic site of the enzyme. This was fully consistent with the structure-activity relationships within this series of cyanooxoindolylacetic acid derivatives.
“…Compounds 1 − 25 were evaluated for their in vitro inhibitory activity against ALR2 as well as against ALR1, SD, and GR. Primary in vitro screening was conducted on a water-soluble enzymatic extract purified from rat lenses. − IC 50 values were determined by linear regression analysis of the log of the concentration−response curve. Compounds 1 − 25 were also assayed for their ability to inhibit SD and two other enzymes not involved in the polyol pathway, namely, ALR1 and GR .…”
Acetic acid derivatives of [1,2,4]triazino[4,3-a]benzimidazole (TBI) were synthesized and tested in vitro and in vivo as a novel class of aldose reductase (ALR2) inhibitors. Compound 3, (10-benzyl[1,2,4]triazino[4,3-a]benzimidazol-3,4(10H)-dion-2-yl)acetic acid, displayed the highest inhibitory activity (IC(50) = 0.36 microM) and was found to be effective in preventing cataract development in severely galactosemic rats when administered as an eyedrop solution. All the compounds investigated were selective for ALR2, since none of them inhibited appreciably aldehyde reductase, sorbitol dehydrogenase, or glutathione reductase. The activity of 3 was lowered by inserting various substituents on the pendant phenyl ring, by shifting the acetic acid moiety from the 2 to the 3 position of the TBI nucleus, or by cleaving the TBI system to yield benzimidazolylidenehydrazines as open-chain analogues. A three-dimensional model of human ALR2 was built, taking into account the conformational changes induced by the binding of inhibitors such as zopolrestat, to simulate the docking of 3 into the enzyme active site. The theoretical binding mode of 3 was fully consistent with the structure-activity relationships in the TBI series and will guide the design of novel ALR2 inhibitors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.